Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27208
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAhmed, A-
dc.contributor.authorJusto, S-
dc.contributor.authorYaghootkar, H-
dc.date.accessioned2023-09-16T21:37:08Z-
dc.date.available2023-09-16T21:37:08Z-
dc.date.issued2023-08-28-
dc.identifierORCID iDs: Altayeb Ahmed https://orcid.org/0000-0003-4748-1991; Hanieh Yaghootkar https://orcid.org/0000-0001-9672-9477.-
dc.identifiere15213-
dc.identifier.citationAhmed, A., Justo, S. and Yaghootkar, H. (2023) 'Genetic scores associated with favourable and unfavourable adiposity have consistent effect on metabolic profile and disease risk across diverse ethnic groups', Diabetic Medicine, 0 (ahead-of-print), e15213, pp. 1 - 9. doi: 10.1111/dme.15213.en_US
dc.identifier.issn0742-3071-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27208-
dc.descriptionData availability statement: All data used in this paper are accessible through https://pan.ukbb.broadinstitute.org/downloads.en_US
dc.descriptionSupporting Information is available online at https://onlinelibrary.wiley.com/doi/10.1111/dme.15213#support-information-section .-
dc.description.abstractCopyright © 2023 The Authors. Aim: This study aims to investigate the associations between genetic risk scores (GRS) for favourable and unfavourable adiposity and a wide range of adiposity-related outcomes across diverse populations. Methods: We utilised previously identified variants associated with favourable (36 variants) and unfavourable (38 variants) adiposity to create GRS for each adiposity phenotype. We used summary statistics from 39 outcomes generated by the Pan-UKB genome-wide association studies Version 0.3, incorporating covariates such as age, sex and principal components in six populations: European (n = 420,531), African (6636), American (980), Central/South Asian (8876), East Asian (2709) and Middle Eastern (1599). Results: The favourable adiposity GRS was associated with a healthy metabolic profile, including lower risk of type 2 diabetes, lower liver enzyme levels, lower blood pressure, higher HDL-cholesterol, lower triglycerides, higher apolipoprotein A, lower apolipoprotein B, higher testosterone, lower calcium and lower insulin-like growth factor 1 generally consistently across all the populations. In contrast, the unfavourable adiposity GRS was associated with an adverse metabolic profile, including higher risk of type 2 diabetes, higher random glucose levels, higher HbA1c, lower HDL-cholesterol, higher triglycerides, higher liver enzyme levels, lower testosterone, and higher C-reactive protein generally consistently across all the populations. Conclusion: The study provides evidence that the genetic scores associated with favourable and unfavourable adiposity have consistent effects on metabolic profiles and disease risk across diverse ethnic groups. These findings deepen our understanding of distinct adiposity subtypes and their impact on metabolic health.en_US
dc.description.sponsorshipH.Y. is funded by Diabetes UK RD Lawrence fellowship (Grant 17/0005594). This work was also supported by a Brunel BRIEF AWARD.en_US
dc.format.extent1 - 9-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherWiley on behalf of Diabetes UK.en_US
dc.rightsCopyright © 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.titleGenetic scores associated with favourable and unfavourable adiposity have consistent effect on metabolic profile and disease risk across diverse ethnic groupsen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1111/dme.15213-
dc.relation.isPartOfDiabetic Medicine-
pubs.issueahead-of-print-
pubs.publication-statusPublished-
pubs.volume0-
dc.identifier.eissn1464-5491-
dc.rights.holderThe Authors-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.1.22 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons